Cayenne Medical
Founded Year
2005Stage
Acquired | AcquiredTotal Raised
$55.19MAbout Cayenne Medical
Cayenne Medical is a medical device company developing new technology for the soft tissue reconstruction segment of the sports medicine market. Cayenne Medical also currently offers products that address previously unmet clinical needs in knee ligament reconstruction, including the AperFix II System and iFix System. The company is focused on providing for the transformation of traditional arthroscopic procedures, by applying advanced technology through minimally invasive techniques.
Cayenne Medical Headquarter Location
16597 North 92nd Street Suite 101
Scottsdale, Arizona, 85260,
United States
480-502-3661
Expert Collections containing Cayenne Medical
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Cayenne Medical is included in 2 Expert Collections, including Medical Devices.
Medical Devices
11,378 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Health IT
7,900 items
Cayenne Medical Patents
Cayenne Medical has filed 59 patents.
The 3 most popular patent topics include:
- Orthopedic surgical procedures
- Shoulder
- Muscles of the upper limb
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
7/2/2018 | 1/18/2022 | Muscles of the upper limb, Shoulder, Orthopedic surgical procedures, Upper limb anatomy, Skeletal system | Grant |
Application Date | 7/2/2018 |
|---|---|
Grant Date | 1/18/2022 |
Title | |
Related Topics | Muscles of the upper limb, Shoulder, Orthopedic surgical procedures, Upper limb anatomy, Skeletal system |
Status | Grant |
Latest Cayenne Medical News
Feb 9, 2020
Global Rotator Cuff Suture Anchor Market Report [2019-2029] further focuses on dominant competitors who play an integral part in satisfying customer’s necessities by all means. It considers that offering an in-depth analysis of leading players is highly essential in order to present an intact and precise Rotator Cuff Suture Anchor market study and therefore it includes organizational, financial, technical, environmental and development related analysis into Rotator Cuff Suture Anchor market competitors and rivalry between them. Strategic and tactical business plans applied by the various market professionals are also evaluated in the Rotator Cuff Suture Anchor market report, which typically covers recent product launches and industry developments through organizations, ventures, combination, and partnerships as well as promotional and branding projects. The Global Rotator Cuff Suture Anchor Market research report is begun with a focus target of helping consumers, market professionals, and financial specialists in increasing the extensive keenness of the global Rotator Cuff Suture Anchor industry. Market size, share, trade, product cost, sales volume, revenue, and development are the absolute most significant variables of the market that have been intensely emphasized in the report. Moreover, it includes a depiction of market elements, Rotator Cuff Suture Anchor market development of main advances, and restrictions. Get Research Report Specimen (Get Higher Priority by Using Company eMail ID ): https://market.us/report/rotator-cuff-suture-anchor-market/request-sample Global Rotator Cuff Suture Anchor Market Top Key Competitors: Arthrex - North America (United States, Canada, Mexico) - South America (Brazil, Argentina, Peru, Chile) - Southeast Asia (Japan, Korea, India, China) - Middle East & Africa (Egypt, Saudi Arabia, Turkey, South Africa) - Europe (Germany, France, United Kingdom, Italy, Russia) Inquire for Any Queries or Information Related About Report (Use Corporate email ID to Get Higher Priority): https://market.us/report/rotator-cuff-suture-anchor-market/inquiry Salient Features of the Global Rotator Cuff Suture Anchor Market Report: • Comprehension of contemporary and potential Rotator Cuff Suture Anchor market trends, dynamics, and growth drivers. • Extensive delineation of Rotator Cuff Suture Anchor market scope, potential, limitations, and restraints. • Thorough insights into leading Rotator Cuff Suture Anchor market competitors alongside detailed corporate profiles. • Investigation of rivalry landscape to gain substantial competitive advantages. • Precise acumen to determine upcoming investment opportunities, challenges, threats, and uncertainties. To Get Instant Access to Market Research Report Here: https://market.us/purchase-report/?report_id=25186 Pricing Details: Single User- $3,495 | Multi-User- $5,100 | Corporate Users- $7,200 What is Single User, Multi-User and Corporate Users license? Single user, multiple user, and corporate licenses are differentiated on the basis of the number of users permitted to use the ordered reports. For a single user license, the distribution of a report copy will be restricted to only one user. Understood by its term, a multiple user license will be restricted to more than one user, typically five users only. Corporate license holders, on the other hand, will be able to distribute a report copy across their organization. Buy Quarterly/Half Year/Annual Subscription for Multiple Reports At Discounted Rate Here: https://market.us/subscribe/ SECTION WISE TABLE OF CONTENTS: 1 Study Coverage
When was Cayenne Medical founded?
Cayenne Medical was founded in 2005.
Where is Cayenne Medical's headquarters?
Cayenne Medical's headquarters is located at 16597 North 92nd Street, Scottsdale.
What is Cayenne Medical's latest funding round?
Cayenne Medical's latest funding round is Acquired.
How much did Cayenne Medical raise?
Cayenne Medical raised a total of $55.19M.
Who are the investors of Cayenne Medical?
Investors of Cayenne Medical include Zimmer Biomet, Split Rock Partners, MB Venture Partners, Fletcher Spaght Ventures, Investor Growth Capital and 4 more.
Who are Cayenne Medical's competitors?
Competitors of Cayenne Medical include Biorez, Endologix, OrthAlign, ArraVasc, Paragon Medical and 12 more.
You May Also Like
Tryton Medical is a developer of stent systems for the treatment of bifurcation lesions. The Tryton Side Branch Stent System is built for bifurcation using Tri-ZONE technology to offer a dedicated strategy for treating bifurcation lesions. Tryton's cobalt chromium stent is deployed in the side branch artery using a standard single-wire balloon-expandable stent delivery system. A conventional drug-eluting stent is then placed in the main vessel. The stent system has received CE Mark and is commercially available throughout Europe, Russia and the Middle East. It is approved in the United States for investigational use only.
Svelte Medical Systems is engaged in the development of highly deliverable balloon expandable stents. The Svelte IDS is designed to realize the clinical, time and cost-savings benefits of direct stenting in a single platform. Svelte is developing a Sirolimus eluting stent that has non-inflammatory properties, potentially making it less irritating to the vessel lining than stents with typical polymeric coatings. The Svelte DES is being developed to have the same drug release kinetics as the market leaders while potentially minimizing inflammation in the vessel to reduce the need for long term dual anti-platelet therapy.
Micell Technologies aims to bring together the clinical advantages of a drug-eluting stent with the long-term safety and stability of a bare metal stent.
Medtronic Sofamor Danek's is focused on solutions for spinal and cranial surgeons. The company has offices located in Memphis, Tennessee, Louisville, Colorado, Warsaw, Indiana, Deggendorf, Germany, and Paris, France, and more than 1,800 associates around the world, per the company.
Afferent Corporation, based in Providence, Rhode Island, is developing of a new class of medical devices to treat chronic neurologic dysfunction. Its lead technology enhances the function of mechanoreceptor cells involved in sensory perception as a means to restore brain function following a stroke, to address complications resulting from diabetic neuropathy, and to improve elderly balance. Afferent's development efforts are being pursued in collaboration with leading biomedical and clinical researchers throughout the United States. Building on this technology platform, Afferent aims to establish a leadership position in the emerging field of neurotherapeutic devices.
SquareOne is developing a stent delivery system.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.